Am I the only who thinks this probably means MYL has given up on Gx copax?
Nope. I'm pretty sure the PR included a few sentences in white font, noting MYL has agreed within the partnership not to further invest in its generic version of Copaxone.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.